← Human Trials & Peer-Reviewed Studies
Is stress management training a useful addition to physician advice and nicotine replacement therapy during smoking cessation in women? Results of a randomized trial.
Plain-language guide to PMID 16295704 (2005): randomized controlled trial of Therapeutic nicotine (patch, non-peptide) in 332 women.
Key Facts
- PMID
- 16295704
- Journal
- American journal of health promotion : AJHP
- Year
- 2005
- Study type
- Randomized Controlled Trial
- Authors
- Slovinec D'Angelo ME et al. (7 authors)
- DOI
- 10.4278/0890-1171-20.2.127
What This Study Did, in Plain Language
What Was Tested
Researchers studied Therapeutic nicotine (patch, non-peptide) in this randomized controlled trial publication.
Who Took Part
The abstract describes 332 women taking part.
PubMed indexes the participants as adults, middle-aged adults and older adults, women only.
Either UC (physician advice and nicotine replacement therapy) or UC plus an eight-session group SM training program (coping skills development relevant to smoking-specific and generic stressors).
How the Study Was Run
The design is described as randomized.
Because people in this Therapeutic nicotine (patch, non-peptide) study were split into groups at random, differences between the groups are less likely to reflect who happened to join each one.
Smoking cessation clinics located within two tertiary care centers in Ottawa, Ontario.
Point prevalence abstinence 2 and 12 months after study intake.
A secondary outcome of interest was change in perceived stress during the intervention period.
What Was Measured
PubMed files the paper under topics including Ontario, Referral and Consultation, Smoking Cessation, Stress, Psychological and Tobacco Use Disorder.
What This Means in Plain Language
The paper is a randomized study of Therapeutic nicotine (patch, non-peptide) in 332 women.
With several hundred people or more, it is a fairly large study for this kind of research.
The abstract goes on to report its results in about 7 sentences; this page does not restate them, so read the paper for the findings and their limits.
The publication is from 2005 (American journal of health promotion : AJHP), a journal based in United States.
More context: the Therapeutic nicotine (patch, non-peptide) compound page, all human trials.
Our Notes on the Compound
Therapeutic nicotine (patch, non-peptide): Pure nicotine as a signaling tool, separated from smoking and vaping.
Related Pages
Source: PubMed record. This explanation is written by PeptideWhiz from the public record. For research and education only. Not medical advice; no dosing information is given.